Skip to main content

Alphabetical Glossary of Terms: Gene Therapy & Immunotherapy, 2nd Edition

The purpose of this glossary is to provide clarification of the most commonly used terms related to gene therapy and immunotherapy. The terms in this glossary are listed alphabetically, with illustrations where appropriate.

Author:

Daniel Kavanagh, PhD
Senior Director, Biosafety and Gene Therapy
WCG Biosafety

Gene Therapy & Immunotherapy Glossary, 2nd Edition

About WCG

WCG is at the forefront of accelerating clinical research worldwide, serving as the trusted and preferred partner to biopharmaceutical and medical device companies, contract research organizations (CROs), research institutions, and site partners. Offering a unique combination of expertise, next-generation data and insights, and tech-enabled solutions, WCG reduces complexity and optimizes study operations and outcomes while maintaining the highest standards of human participant protection. For more than 55 years, WCG has maintained a relentless commitment to efficiency, safety, and impact, empowering clinical trials to deliver life-improving therapies swiftly. For more information, please visit wcgclinical.com or follow us on LinkedIn or X @WCGClinical